Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation TCT 2023

AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

Presenter: Edip Gurol

October 26, 2023

Presentation TCT 2023

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

Presenter: Jens Erik Nielsen-Kudsk

October 25, 2023

Presentation TCT 2023

US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation

Presenter: Saibal Kar

October 25, 2023

Presentation TCT 2023

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

October 25, 2023

Presentation TCT 2023

Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device

Presenter: Julia Seeger

October 25, 2023

Presentation TCT 2023

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

Presenter: Sanjit Jolly

October 25, 2023

Presentation EuroPCR 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presenter: Xavier Freixa

May 17, 2023

Advertisement

AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content